Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 50...
FDA Drug Recall #D-1274-2020 — Class II — May 13, 2020
Recall Summary
| Recall Number | D-1274-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 13, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | West-Ward Columbus Inc |
| Location | Columbus, OH |
| Product Type | Drugs |
| Quantity | 68,376 bottles |
Product Description
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.
Reason for Recall
Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
Distribution Pattern
USA Nationwide
Lot / Code Information
Lot #: a) 71846B, Exp 6/2021; b) 71726A, Exp 6/2020; 71846B, 71853A, Exp 6/2021
Other Recalls from West-Ward Columbus Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0183-2025 | Class III | Methadone Hydrochloride Tablets, USP, 5mg, 10x1... | Dec 19, 2024 |
| D-0066-2024 | Class III | Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-D... | Sep 22, 2023 |
| D-1490-2020 | Class III | Leucovorin Calcium Tablets USP, 10 mg, Rx only,... | Jul 22, 2020 |
| D-1282-2020 | Class III | Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets... | May 13, 2020 |
| D-1863-2019 | Class II | Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL... | Sep 9, 2019 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.